# BioMarin Pharmaceutical (BMRN): value investors who own it

1 value investor held BioMarin Pharmaceutical in their Q3 2026 13F, led by Dodge & Cox. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Dodge & Cox | 0.4% | $849m | Added +1.9% | 27 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-02 | Davis George Eric | EVP, Chief Legal Officer | Sold | 17557 | $1.2m |

## Fund holders

| Fund | Manager | Weight | Value | As at |
| --- | --- | --- | --- | --- |
| Dodge & Cox Global Stock Fund | Dodge & Cox | 0.3% | $43.4m | 2026-06-30 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/bmrn). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.